Strategies for reducing sudden cardiac death: Application of microvolt T-wave alternans testing in clinical practice

Heart Rhythm

Volumn 6, Issue 3 SUPPL., 2009, Pages

  Mirro, Michael J ^a  

^a Parkview Health System   (United States)

Author keywords

Noninvasive risk stratification; Sudden cardiac death; T wave alternans

Indexed keywords

AMIODARONE;

ARTICLE; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; EDUCATION PROGRAM; HEART ARREST; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MEDICAL INFORMATION SYSTEM; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SUDDEN DEATH; T WAVE; T WAVE ALTERNANS;

ALGORITHMS; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HUMANS; MASS SCREENING; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SYSTOLE; TIME FACTORS;

EID: 61349148805     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.01.001     Document Type: Article

References (30)

1. Chugh S.S., Jui J., Gunson K., et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol 44 (2004) 1268-1275
2. Huikuri H.V., Castellanos A., and Myerburg R.J. Sudden death due to cardiac arrhythmias. N Engl J Med 345 (2001) 1473-1482
3. Zipes D.P., and Wellens H.J.J. Sudden cardiac death. Circulation 98 (1998) 2334-2351
4. Albert C.M., Chae C.U., Grodstein F., et al. Prospective study of sudden cardiac death among women in the United States. Circulation 107 (2003) 2096-2101
5. Bayes de Luna A., Coumel P., and Leclercq J.F. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 117 (1989) 151-159
6. Armoundas A.A., Hohnloser S.H., Ikeda T., et al. Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?. Nat Clin Pract Cardiovasc Med 2 (2005) 522-528
7. Gehi A.K., Stein R.H., Metz L.D., et al. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol 46 (2005) 75-82
8. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
9. Connolly S.J., Gent M., Roberts R.S., et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101 (2000) 1297-1302
10. Kuck K.H., Cappato R., Siebels J., et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102 (2000) 748-754
11. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
12. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
13. Buxton A.E., Lee K.L., Fisher J.D., et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341 (1999) 1882-1890
14. Moss A.J., Hall W.J., Cannom D.S., et al. Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335 (1996) 1933-1940
15. Hernandez A.F., Fonarow G.C., Liang L., et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA 298 (2007) 1525-1532
16. Quan K.J., Amit G., and Costantini O. Awareness of referral criteria for implantable defibrillator implantation amongst primary care physicians (abstr). Heart Rhythm 5 (2008) S46
17. Salvo J., and Bersohn M.M. ICD referral rate from a cardiomyopathy clinic (abstr). Europace 10 Suppl 1 (2008) i96
18. Buxton A.E., Lee K.L., Hafley G., et al. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease. J Am Coll Cardiol 50 (2007) 1150-1157
19. Goldenberg I., Vyas A.K., Hall W.J., et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 51 (2008) 288-296
20. Chow T., Kereiakes D.J., Bartone C., et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol 47 (2006) 1820-1827
21. Salerno-Uriarte J.A., De Ferrari G.M., Klersy C., et al. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA study. J Am Coll Cardiol 50 (2007) 1896-1904
22. de Vreede-Swagemakers J.J., Gorgels A.P., Dubois-Arbouw W.I., et al. Out-of-hospital cardiac arrest in the 1990s: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 30 (1997) 1500-1505
23. Myerburg R.J., Mitrani R., Interian Jr. A., et al. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. Circulation 97 (1998) 1514-1521
24. Yan A.T., Shayne A.J., Brown K.A., et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114 (2006) 32-39
25. Hsia J., Jablonski K.A., Rice M.M., et al. Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic function. Am J Cardiol 101 (2008) 457-461
26. Baravelli M., Salerno-Uriarte D., Guzzetti D., et al. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study. Int J Cardiol 105 (2005) 53-57
27. Exner D.V., Kavanagh K.M., Slawnych M.P., et al. Noninvasive risk assessment early after a myocardial infarction-the REFINE study. J Am Coll Cardiol 50 (2007) 2275-2284
28. Ikeda T., Yoshino H., Sugi K., et al. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study. J Am Coll Cardiol 48 (2006) 2268-2274
29. Radoi N., and Ionescu D.D. Microvolt T wave alternans may be used as a risk stratifier in post myocardial infarction patients without left ventricular systolic dysfunction (abstract). Europace 10 Suppl 1 (2008) i16
30. Greenberg H., Case R.B., Moss A.J., et al. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 43 (2004) 1459-1465